(Q38147870)

29 August 2017

Glucocorticoid sensitivity in health and disease (English)

1 reference

29 August 2017

Rogier A Quax

1

1 reference

29 August 2017

Laura Manenschijn

2

1 reference

29 August 2017

Jan W Koper

3

1 reference

29 August 2017

Johanna M Hazes

4

1 reference

29 August 2017

Steven W J Lamberts

5

1 reference

29 August 2017

Elisabeth F C van Rossum

6

1 reference

29 August 2017

Richard A Feelders

7

1 reference

29 August 2017

1 October 2013

1 reference

Nature Reviews Endocrinology

29 August 2017

1 reference

29 August 2017

9

1 reference

29 August 2017

11

1 reference

29 August 2017

670-686

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2013.183

29 August 2017

0 references

cites work

Antiinflammatory action of glucocorticoids--new mechanisms for old drugs

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Clinical features associated with glucocorticoid receptor polymorphisms. An overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Primary generalized familial and sporadic glucocorticoid resistance (Chrousos syndrome) and hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoids and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoid sensitivity in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoid action networks and complex psychiatric and/or somatic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoid signaling in the cell. Expanding clinical implications to complex human behavioral and somatic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Dynamic regulation of glucocorticoid signalling in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Ultradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcription.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Circadian rhythm transcription factor CLOCK regulates the transcriptional activity of the glucocorticoid receptor by acetylating its hinge region lysine cluster: potential physiological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Genomic and nongenomic effects of glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Mechanisms and resistance in glucocorticoid control of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Exploring the molecular mechanisms of glucocorticoid receptor action from sensitivity to resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Use of gene expression profiling to identify a novel glucocorticoid sensitivity determining gene, BMPRII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Interaction of the glucocorticoid receptor with the chromatin landscape

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Primary structure and expression of a functional human glucocorticoid receptor cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoid receptor (GR) beta has intrinsic, GRalpha-independent transcriptional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Human glucocorticoid receptor beta binds RU-486 and is transcriptionally active.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Interaction of glucocorticoid receptor isoforms with transcription factors AP-1 and NF-kappaB: lack of effect of glucocorticoid receptor beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Evidence that the beta-isoform of the human glucocorticoid receptor does not act as a physiologically significant repressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Overexpression of the human glucocorticoid receptor alpha and beta isoforms inhibits AP-1 and NF-kappaB activities hormone independently

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

The glucocorticoid receptor beta isoform can mediate transcriptional repression by recruiting histone deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Insertion of an amino acid in the DNA-binding domain of the glucocorticoid receptor as a result of alternative splicing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

The glucocorticoid responses are shaped by molecular chaperones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Membrane glucocorticoid receptors (mGCR) are expressed in normal human peripheral blood mononuclear cells and up-regulated after in vitro stimulation and in patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Rapid glucocorticoid effects on immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Emerging pathways of non-genomic glucocorticoid (GC) signalling in T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Genomic and non-genomic effects of glucocorticoids on aggressive behavior in male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Corticosteroid Inhibition of ACTH Secretion*

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Rapid non-genomic feedback effects of glucocorticoids on CRF-induced ACTH secretion in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Histone deacetylase-2 and airway disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Altered subcellular distribution of MSK1 induced by glucocorticoids contributes to NF-kappaB inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Cross-talk between nuclear receptors and nuclear factor kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Modulation of glucocorticoid receptor function via phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoids and the innate immune system: crosstalk with the toll-like receptor signaling network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoids regulate tristetraprolin synthesis and posttranscriptionally regulate tumor necrosis factor alpha inflammatory signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoid sensitivity in young healthy individuals: in vitro and in vivo studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Seasonal variation in glucocorticoid receptor binding characteristics in human mononuclear leucocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Biological and diurnal variation in glucocorticoid sensitivity detected with a sensitive in vitro dexamethasone suppression of cytokine production assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Circadian Patterns of Stress-Induced ACTH Secretion Are Modified by Corticosterone Responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Age-associated changes of pituitary-adrenocortical hormone regulation in humans: importance of gender.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Basal hypothalamo-pituitary-adrenal axis activity and corticotropin feedback in young and older men: relationships to magnetic resonance imaging-derived hippocampus and cingulate gyrus volumes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Stress, glucocorticoids and ageing of the immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

The role of 11β-hydroxysteroid dehydrogenase type 2 in human hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Expression of the human glucocorticoid receptor splice variants alpha, beta, and P in peripheral blood mononuclear leukocytes in healthy controls and in patients with hyper- and hypocortisolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

The physiology of human glucocorticoid receptor beta (hGRbeta) and glucocorticoid resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Molecular mechanisms regulating glucocorticoid sensitivity and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoid resistance in inflammatory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoid receptor isoforms generate transcription specificity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

The rs4844880 polymorphism in the promoter region of the HSD11B1 gene associates with bone mineral density in healthy and postmenopausal osteoporotic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Analysis of the 11beta-hydroxysteroid dehydrogenase type 2 gene (HSD11B2) in human essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Identification of the BclI polymorphism in the glucocorticoid receptor gene: association with sensitivity to glucocorticoids in vivo and body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoid sensitivity is determined by a specific glucocorticoid receptor haplotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Meta-analysis on the effect of the N363S polymorphism of the glucocorticoid receptor gene (GRL) on human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Molecular evidence for a link between the N363S glucocorticoid receptor polymorphism and altered gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Increased expression of the glucocorticoid receptor-A translational isoform as a result of the ER22/23EK polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

The ER22/23EK polymorphism in the glucocorticoid receptor gene is associated with a beneficial body composition and muscle strength in young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Association of the ER22/23EK polymorphism in the glucocorticoid receptor gene with survival and C-reactive protein levels in elderly men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

AUUUA motifs in the 3'UTR of human glucocorticoid receptor alpha and beta mRNA destabilize mRNA and decrease receptor protein expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Familial/sporadic glucocorticoid resistance syndrome and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Generalized glucocorticoid resistance caused by a novel two-nucleotide deletion in the hormone-binding domain of the glucocorticoid receptor gene NR3C1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoid resistance syndrome: A diagnostic and therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Practice patterns in patients at risk for glucocorticoid-induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

New insights into the role and mechanism of macrophage migration inhibitory factor in steroid-resistant patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Polymorphisms in the glucocorticoid receptor gene that modulate glucocorticoid sensitivity are associated with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

A glucocorticoid receptor gene haplotype (TthIII1/ER22/23EK/9beta) is associated with a more aggressive disease course in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoid receptor gene polymorphisms and disease activity during pregnancy and the postpartum period in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoid receptor gene polymorphisms and glucocorticoid resistance in inflammatory bowel disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Endogenous macrophage migration inhibitory factor modulates glucocorticoid sensitivity in macrophages via effects on MAP kinase phosphatase-1 and p38 MAP kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Genomewide association between GLCCI1 and response to glucocorticoid therapy in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Molecular determinants of glucocorticoid sensitivity and resistance in acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Differential expression, function and response to inflammatory stimuli of 11beta-hydroxysteroid dehydrogenase type 1 in human fibroblasts: a mechanism for tissue-specific regulation of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Reduced capacity for the reactivation of glucocorticoids in rheumatoid arthritis synovial cells: possible role of the sympathetic nervous system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Local and systemic glucocorticoid metabolism in inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

A gene expression signature for recent onset rheumatoid arthritis in peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Expression profiles of human 11beta-hydroxysteroid dehydrogenases type 1 and type 2 in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Predicting therapeutic outcome in severe ulcerative colitis by measuring in vitro steroid sensitivity of proliferating peripheral blood lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Resistance to methylprednisolone in cultures of blood mononuclear cells from glucocorticoid-resistant asthmatic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Corticosteroid resistance in a subpopulation of multiple sclerosis patients as measured by ex vivo dexamethasone inhibition of LPS induced IL-6 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Flow cytometry analysis of glucocorticoid receptor expression and binding in steroid-sensitive and steroid-resistant patients with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoid receptor downregulation in early diagnosed rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoid receptors in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoid sensitivity in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Increased glucocorticoid receptor beta in airway cells of glucocorticoid-insensitive asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

The relationship between the expression of the glucocorticoid receptor in biopsied colonic mucosa and the glucocorticoid responsiveness of ulcerative colitis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoid receptor beta in acute and chronic inflammatory conditions: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

The differential expression of corticosteroid receptor isoforms in corticosteroid-resistant and -sensitive patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Alpha and beta glucocorticoid receptors: relevance in airway diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoid receptor isoform expression does not predict steroid treatment response in IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoid receptor-beta up-regulation and steroid resistance induction by IL-17 and IL-23 cytokine stimulation in peripheral mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

The dominant negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Steroid up-regulation of FKBP51 and its role in hormone signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Dexamethasone-induced FKBP51 expression in peripheral blood mononuclear cells could play a role in predicting the response of asthmatics to treatment with corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Steroid receptor phosphorylation: a key modulator of multiple receptor functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

p38 mitogen-activated protein kinase-γ inhibition by long-acting β2 adrenergic agonists reversed steroid insensitivity in severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Restoration of corticosteroid sensitivity by p38 mitogen activated protein kinase inhibition in peripheral blood mononuclear cells from severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Mechanisms of disease: macrophage migration inhibitory factor in SLE, RA and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Corticosteroid resistance in sepsis is influenced by microRNA-124--induced downregulation of glucocorticoid receptor-α.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Role for microRNAs in regulating glucocorticoid response and resistance in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Aberrant microRNA-182 expression is associated with glucocorticoid resistance in lymphoblastic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoid receptor-binding characteristics in severe asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Decreased corticosensitivity in quiescent Crohn's disease: an ex vivo study using whole blood cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Cortisol in hair and the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

High long-term cortisol levels, measured in scalp hair, are associated with a history of cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Cortisol, obesity, and the metabolic syndrome: a cross-sectional study of obese subjects and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoid receptor gene and risk of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoid receptor gene, low-grade inflammation, and heart failure: the Heart and Soul study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Skeletal muscle glucocorticoid receptor density and insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Local and systemic impact of transcriptional up-regulation of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11beta-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

DST studies in psychotic depression: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Prospective prediction of major depressive disorder from cortisol awakening responses in adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Stress responsiveness varies over the ultradian glucocorticoid cycle in a brain-region-specific manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Twenty-four-hour ACTH and cortisol pulsatility in depressed women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoid receptor gene haplotype predicts increased risk of hospital admission for depressive disorders in the Helsinki birth cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Rationale for HDAC inhibitor therapy in autoimmunity and transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Targeting histone deacetylases for the treatment of cancer and inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Histone deacetylase inhibitors MS-275 and SAHA induced growth arrest and suppressed lipopolysaccharide-stimulated NF-kappaB p65 nuclear accumulation in human rheumatoid arthritis synovial fibroblastic E11 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Inhibition of HDAC activity by ITF2357 ameliorates joint inflammation and prevents cartilage and bone destruction in experimental arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

MIF in autoimmunity and novel therapeutic approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Crosstalk between glucocorticoids and mitogen-activated protein kinase signalling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Kinase inhibitors: a new class of antirheumatic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Clinical relevance of the expression of P-glycoprotein on peripheral blood lymphocytes to steroid resistance in patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Targeting inflammation using selective glucocorticoid receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Selective glucocorticoid receptor modulators: future of glucocorticoid immunosuppressive therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Obesity and corticosteroids: 11beta-hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

The 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

BclI polymorphism of the glucocorticoid receptor gene is associated with increased bone resorption in patients on glucocorticoid replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Premature mortality in patients with Addison's disease: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Differential regulation of synthetic glucocorticoids on gene expression levels of glucocorticoid-induced leucine zipper and interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

In vitro glucocorticoid sensitivity is associated with clinical glucocorticoid therapy outcome in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

BclI Glucocorticoid Receptor Polymorphism Is Associated With Greater Body Fatness: The Hoorn and CODAM Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Interactions among the glucocorticoid receptor, lipoprotein lipase and adrenergic receptor genes and abdominal fat in the Québec Family Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Cryptochromes mediate rhythmic repression of the glucocorticoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Neuroendocrine-immune interactions in rheumatoid arthritis: mechanisms of glucocorticoid resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Binding characteristics of transcortin in human plasma in normal individuals, pregnancy and liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Regulation of the human glucocorticoid receptor by long-term and chronic treatment with glucocorticoid

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Functional Characterization of the Natural Human Glucocorticoid Receptor (hGR) Mutants hGRαR477H and hGRαG679S Associated with Generalized Glucocorticoid Resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Association between a variant in the 11 beta-hydroxysteroid dehydrogenase type 2 gene and primary hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoid receptor polymorphism affects transrepression but not transactivation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Molecular identification and characterization of a and b forms of the glucocorticoid receptor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Genetic variants in the glucocorticoid receptor gene (NR3C1) and cardiovascular disease risk. The Leiden 85-plus Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

A patient with hypocortisolism and Cushing's syndrome-like manifestations: cortisol hyperreactive syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

The effect of methylprednisolone on proliferation of PBMCs obtained from steroid-sensitive and steroid-resistant rheumatoid arthritis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Response to glucocorticoids at 2 weeks predicts the effectiveness of DMARD induction therapy at 3 months: post hoc analyses from the tREACH study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Genetics of glucocorticoids in asthma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Differential regulation of 11β-hydroxysteroid dehydrogenase-1 by dexamethasone in glucocorticoid-sensitive and -resistant childhood lymphoblastic leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Increased expression of multidrug resistance of P-glycoprotein on Th1 cells correlates with drug resistance in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Levels of glucocorticoid receptor and its ligand determine sensitivity and kinetics of glucocorticoid-induced leukemia apoptosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Relationship between glucocorticoid receptor and response to glucocorticoid therapy in ulcerative colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Expression of glucocorticoid receptor beta in lymphocytes of patients with glucocorticoid-resistant ulcerative colitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoid resistance in asthma is associated with elevated in vivo expression of the glucocorticoid receptor beta-isoform

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Expression of mRNA for glucocorticoid receptors in peripheral blood mononuclear cells of patients with Crohn's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Glucocorticoid receptor alpha, beta and gamma expression vs in vitro glucocorticod resistance in childhood leukemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Cross-talk between nuclear factor-kappa B and the steroid hormone receptors: mechanisms of mutual antagonism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Nontranscriptional actions of the glucocorticoid receptor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Cortisol--cause and cure for metabolic syndrome?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Polymorphisms of the glucocorticoid receptor gene and major depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Association of corticotropin-releasing hormone receptor1 gene SNP and haplotype with major depression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Prevention of the onset and progression of collagen-induced arthritis in rats by the potent p38 mitogen-activated protein kinase inhibitor FR167653

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2013.183

Differential adaptation of glucocorticoid sensitivity of peripheral blood mononuclear leukocytes in patients with sepsis or septic shock

31 March 2020

1 reference

12 December 2020

Glucocorticoid receptor up-regulation in early rheumatoid arthritis treated with low dose prednisone or placebo

1 reference

12 December 2020

Corticosteroid-resistant chronic asthma and monocyte complement receptors

1 reference

12 December 2020

Wide variation in lymphocyte steroid sensitivity among healthy human volunteers.

1 reference

12 December 2020

Normocortisolemic Cushing's syndrome initially presenting with increased glucocorticoid receptor numbers

1 reference

12 December 2020

Glucocorticoid receptors in systemic lupus erythematosus

1 reference

12 December 2020

Elevated plasma cortisol concentrations: a link between low birth weight and the insulin resistance syndrome?

1 reference

12 December 2020

Expression analysis of the glucocorticoid receptor and the nuclear factor-kB subunit p50 in lymphocytes from patients with rheumatoid arthritis.

1 reference

12 December 2020

Glucocorticoid receptor and heat shock protein 90 in peripheral blood mononuclear cells from asthmatics

1 reference

12 December 2020

Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids

1 reference

12 December 2020

Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids

1 reference

12 December 2020

Expression of the mRNA coding for 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue from obese patients: an in situ hybridization study

1 reference

12 December 2020

Response to glucocorticoid treatment in rheumatoid arthritis: in vitro cell mediated immune assay predicts in vivo responses

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2013.183

1 reference

29 August 2017

1 reference